MedExel Selected as a Participant in the P300 Project
MedExel Co., Ltd. announced on October 14 that it has been selected as a participant in the P300 Project, a program that supports companies in participating in international procurement markets, including bid participation and securing export financing through organizations like the UN.
MedExel is a manufacturer of diabetes-related medical consumables, specializing in pen needles, which it has exported as OEM products to the U.S. and Europe for many years. Recently, the company has also begun exporting its own brand, “TopFine,” to countries such as Iran, Colombia, and China.
As a participant in the P300 Project, MedExel will receive support in accessing bidding information and opportunities in international procurement markets. This opportunity will help the company expand its participation in bids while promoting Korea’s technological excellence on a global stage.
Through this project, MedExel plans to actively promote and participate in bids with its product, TopFine, to highlight the competitive quality of its pen needles, contributing to the development of Korea’s national brand image.
